BTK-IN-16
BTK-IN-16 is a dual inhibitor of BTK wild type and C481S mutant of Bruton’s tyrosine kinase (BTK) with IC50s of 5.1 and 4.1 μM. BTK-IN-16 can be used for the research of autoimmune diseases and chronic lymphocytic leukemia[1].
Product Specifications
CAS Number
[2883232-92-4]
UNSPSC
12352005
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/btk-in-16.html
Solubility
10 mM in DMSO
Smiles
COC1=CC(C(C=C1OC)=NC=N2)=C2NC3=CC=CN=C3
Molecular Formula
C15H14N4O2
Molecular Weight
282.30
References & Citations
[1]Kim T, et al. Two-Track Virtual Screening Approach to Identify the Dual Inhibitors of Wild Type and C481S Mutant of Bruton's Tyrosine Kinase. J Chem Inf Model. 2022 Aug 24.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7061324 Inquire
Recombinant Escherichia coli Uncharacterized protein yfjW (yfjW), partial
Ask
View Details MBS1446416-01 0.02 mg (E-Coli)
Recombinant Oryza sativa subsp. japonica Heat stress transcription factor A-2c (HSFA2C)
Ask
View Details MBS1446416-02 0.02 mg (Yeast)
Recombinant Oryza sativa subsp. japonica Heat stress transcription factor A-2c (HSFA2C)
Ask
View Details MBS1446416-03 0.1 mg (E-Coli)
Recombinant Oryza sativa subsp. japonica Heat stress transcription factor A-2c (HSFA2C)
Ask
View Details